88
Participants
Start Date
June 10, 2024
Primary Completion Date
February 2, 2027
Study Completion Date
February 2, 2027
Dostarlimab
Dostarlimab will be administered.
Belrestotug
Belrestotug will be administered.
Pembrolizumab
Pembrolizumab will be administered.
Placebo
Placebo will be administered.
GSK Investigational Site, Kaohsiung City
GSK Investigational Site, Adana
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Florida
GSK Investigational Site, Hasselt
GSK Investigational Site, Plovdiv
GSK Investigational Site, Córdoba
GSK Investigational Site, Mont Gaston
GSK Investigational Site, Haskovo
GSK Investigational Site, Córdoba
GSK Investigational Site, A Coruña
GSK Investigational Site, Hamburg
GSK Investigational Site, Turku
GSK Investigational Site, Incheon
GSK Investigational Site, Jaén
GSK Investigational Site, La Paz BCS
GSK Investigational Site, Taipei
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Aravaca
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Cartagena Murcia
GSK Investigational Site, Pamplona
GSK Investigational Site, Oviedo
GSK Investigational Site, Pessac
GSK Investigational Site, Ocala
GSK Investigational Site, Istanbul
GSK Investigational Site, Las Palmas de Gran Canar
GSK Investigational Site, Rennes
GSK Investigational Site, Salamanca
GSK Investigational Site, Nashville
GSK Investigational Site, Santander
GSK Investigational Site, Lexington
GSK Investigational Site, Lexington
GSK Investigational Site, Seville
GSK Investigational Site, Daegu
GSK Investigational Site, Guadajalara
GSK Investigational Site, Valladolid
GSK Investigational Site, Ann Arbor
GSK Investigational Site, BaracaldoVizcaya
GSK Investigational Site, Angers
GSK Investigational Site, Lorient
GSK Investigational Site, Omaha
GSK Investigational Site, Kuopio
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Luis Potosí City
GSK Investigational Site, Limoges
GSK Investigational Site, Boulogne-Billancourt
GSK Investigational Site, Honolulu
GSK Investigational Site, Olympia
GSK Investigational Site, New Delhi
GSK Investigational Site, Gūrgaon
GSK Investigational Site, Shanghai
GSK Investigational Site, Nanjing
GSK Investigational Site, Hefei
GSK Investigational Site, Hangzhou
GSK Investigational Site, Gokul Shirgoan
GSK Investigational Site, Apex Wellness Hospital
GSK Investigational Site, Bangalore
GSK Investigational Site, Bangalore
GSK Investigational Site, Belagavi
GSK Investigational Site, Chengdu
GSK Investigational Site, Kolkata
GSK Investigational Site, Bhubaneshwar
GSK Investigational Site, Bhubaneswar
GSK Investigational Site, Cipoletti Rio Negro
GSK Investigational Site, Ciudad Autonoma de Buenos Aire
GSK Investigational Site, Ciudad Autonoma de Bueno
GSK Investigational Site, Mendoza
GSK Investigational Site, Rosario
GSK Investigational Site, Rosario
GSK Investigational Site, San Miguel de Tucumán
GSK Investigational Site, Barretos
GSK Investigational Site, Belém
GSK Investigational Site, CuritibaPR
GSK Investigational Site, Florianópolis
GSK Investigational Site, Fortaleza
GSK Investigational Site, Londrina
GSK Investigational Site, Porto VelhoRondOnia
GSK Investigational Site, Salvador
GSK Investigational Site, SAo JosE Do Rio PretoSP
GSK Investigational Site, São Paulo
GSK Investigational Site, Vitória
GSK Investigational Site, Halifax
GSK Investigational Site, Hangzhou
GSK Investigational Site, Shatin
GSK Investigational Site, Panama City
GSK Investigational Site, Punta Pacifica Panama City Panama
GSK Investigational Site, Ahmedabad-380016
GSK Investigational Site, Aichi
GSK Investigational Site, Chiba
GSK Investigational Site, Ehime
GSK Investigational Site, Ehime
GSK Investigational Site, Fukuoka
GSK Investigational Site, Fukuoka
GSK Investigational Site, Gifu
GSK Investigational Site, Gunma
GSK Investigational Site, Hiroshima
GSK Investigational Site, Hokkaido
GSK Investigational Site, Hyōgo
GSK Investigational Site, Hyōgo
GSK Investigational Site, Kanagawa
GSK Investigational Site, Kyoto
GSK Investigational Site, Mie
GSK Investigational Site, Miyagi
GSK Investigational Site, Miyagi
GSK Investigational Site, Nagasaki
GSK Investigational Site, Niigata
GSK Investigational Site, Okayama
GSK Investigational Site, Osaka
GSK Investigational Site, Osaka
GSK Investigational Site, Tochigi
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
GSK Investigational Site, Tottori
GSK Investigational Site, Wakayama
GSK Investigational Site, Mexico City
GSK Investigational Site, Alkmaar
GSK Investigational Site, Enschede
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Seoul
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Gävle
GSK Investigational Site, Ankara
GSK Investigational Site, Ankara
Lead Sponsor
Collaborators (1)
iTeos Therapeutics
INDUSTRY
GlaxoSmithKline
INDUSTRY